Richard Henry Mattson MD

Richard Mattson, MD, is recognized worldwide for his expertise in the diagnosis and treatment of epilepsy, which he describes as “a treatable condition with many neuroscientific insights. This disorder can be successfully managed in most patients.”

Dr. Mattson, who cares for both adult and pediatric patients, has contributed to making the Yale Medicine Epilepsy & Seizure Center a leader in research, education and treatment. He was the first doctor to report the use of sleep deprivation as an activating factor in epilepsy and the electroencephalogram; and one of the first to develop a continuous epilepsy monitoring unit. He directed the first and largest landmark clinical trial comparing anti-epileptic drugs.